Funding for this research was provided by:
Utah Science Technology and Research
Received: 28 June 2019
Revised: 15 September 2019
Accepted: 30 September 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: Not applicable
: We confirm the table and figures in the manuscript are original for this article.
: Teruo Okano holds equity in CellSeed, Inc. (Japan) as an investor/developer designated on the patent for temperature-responsive culture surfaces. No other competing financial interests exist. The authors declare that they have no competing interests.